• Patients with life-threatening hematologic malignancies, including acute myeloid leukemia, acute lymphoblastic leukemia, advanced myelodysplastic syndrome, advanced chronic myeloid leukemia.
• Age less than 51 years.
Other eligibility criteria may apply.
• Patients with HLA-matched related or unrelated donors.
• Patients with poor heart, lung, kidney, or liver function.
• Patients with HIV.
Other exclusion criteria may apply.